Gastroesophageal reflux disease (GERD) continues to be among the most common
diseases seen by gastroenterologists, surgeons, and primary care physicians. Our …

Management of gastroesophageal reflux disease (GERD) commonly starts with an empiric
trial of proton pump inhibitor (PPI) therapy and complementary lifestyle measures, for …

Up to 40% of patients with symptoms suspicious of gastroesophageal reflux disease (GERD)
do not respond completely to proton pump inhibitor (PPI) therapy. The term “refractory …

Objective: To develop a North American Society for Pediatric Gastroenterology, Hepatology,
and Nutrition (NASPGHAN) and European Society for Pediatric Gastroenterology …

Guidelines for the diagnosis and treatment of gastroesophageal reflux disease (GERD) were
published in 1995 and updated in 1999. These and other guidelines undergo periodic …

Approximately a third of patients with suspected gastro-oesophageal reflux disease are
resistant or partial responders to proton pump inhibitors (PPIs). Many of these patients do …

Background The endoscopic radiofrequency procedure (Stretta) has been used for more
than a decade to treat patients with gastroesophageal reflux disease (GERD). However, the …

Gastro-oesophageal reflux disease refers to reflux of gastric contents into the oesophagus
leading to oesophagitis, reflux symptoms sufficient to impair quality of life, or long-term …

Objectives To assess the quantity and quality of randomised, sham-controlled studies of
surgery and invasive procedures and estimate the treatment-specific and non-specific …

BACKGROUND: Gastroesophageal reflux disease (GERD) is the most prevalent acid‐
related disorder in Canada and is associated with significant impairment of health‐related …